Sharemaestro Newsreel

Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference

Progyny, Inc. announced that its CEO, Pete Anevski, will present at the Canaccord Genuity 46th Annual Growth Conference on Tuesday, August 11, 2026, at 3:30 p.m. ET. The presentation will be accessible via a live audiocast and replay on Progyny’s investor relations website. Progyny …

Cigna Group (NYSE: CI) EVP sells 19,436 shares after option exercise

Cigna Group's EVP, Nicole S. Jones, exercised 15,346 employee stock options and subsequently sold 19,436 common shares on August 4-5, 2026. These transactions, valued at approximately $5.37 million, were conducted under a pre-adopted Rule 10b5-1 trading plan. After the sales, Jones retains 28,557 direct …

Higher Q2 profit and share buybacks at Progyny (NASDAQ: PGNY)

Pacer Advisors Inc. Sells 17,053 Shares of Cigna Group $CI

Pacer Advisors Inc. significantly reduced its stake in Cigna Group (NYSE:CI) during the first quarter, selling 17,053 shares, which represents a 56.4% decrease. Despite this, institutional investors collectively own a substantial 86.99% of Cigna's stock, and Wall Street analysts generally maintain a "Moderate Buy" …

Annexon, Inc. Reports Early Clinical Responses in First U.S. and European Patient Cohort of GBS FORWARD Study with Tanruprubart

Annexon, Inc. announced early positive results from the first ten U.S. and European patients in its GBS FORWARD study of tanruprubart. The study showed rapid and clinically meaningful improvements in strength and reduced disability within days for patients with Guillain-Barré syndrome (GBS), a life-threatening …

Progyny, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:PGNY) 2026-08-07

Progyny, Inc. has published its Q2 2026 earnings call presentation. The company reported EPS of $0.55, beating estimates by $0.03, and revenue of $350.51 million, surpassing expectations by $1.86 million, representing a 5.30% year-over-year increase. This article provides access to the slide deck presented …

Roman DBDR Acquisition II : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)

Roman DBDR Acquisition Corp. II, a blank check company, filed its quarterly report for the quarter ending June 30, 2026 (Form 10-Q). The report details the company's financial condition, results of operations, and ongoing efforts to complete a business combination, specifically with ThomasLloyd. The …

Centene Corp (CNC) Earnings Forecast: Future EPS & Revenue Growth Estimates

Centene Corp (CNC) has an earnings forecast score of 6.87, ranking 48th in the Healthcare Providers & Services industry, with an average price target of $40.00. Analysts' ratings show a majority "Hold" signal based on 23 analysts. The company's expected revenue for the next …

Graves Light Lenhart Wealth Inc. Acquires 3,603 Shares of Elevance Health, Inc. $ELV

Graves Light Lenhart Wealth Inc. significantly increased its stake in Elevance Health (NYSE:ELV) by 124.2% in Q2, adding 3,603 shares to reach a total of 6,505 shares valued at $2.52 million. Wall Street analysts maintain a "Moderate Buy" consensus for ELV, with an average …

Oscar Health (NYSE: OSCR) swings to Q2 2026 profit after prior-year loss

Oscar Health (NYSE: OSCR) reported a significant return to profitability in Q2 2026, achieving a net income of $361.8 million, a substantial improvement from a loss of $228.4 million in the prior year. Total revenue for the quarter reached $4.88 billion, up 71% year-over-year, …

Insider Selling: Cigna Group (NYSE:CI) Insider Sells $5,369,583.72 in Stock

Cigna Group insider Nicole Jones sold 19,436 shares of the company's stock for approximately $5.37 million, reducing her direct ownership by 41.63%. This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan. Despite the insider selling, Cigna's shares rose, and the company reported …

Why Cigna Group (CI) Is Down 9.0% After Strong Q2 Results Meet PBM and Regulatory Jitters

Cigna Group (CI) reported strong Q2 2026 results with increased revenue and net income, alongside continued share repurchases. Despite this, the stock dropped 9.0% due to heightened regulatory scrutiny over its pharmacy benefit management (PBM) operations and ongoing business portfolio review. Analysts have expressed …

Progyny Inc (PGNY) (Q2 2026) Earnings Call Highlights: Record Revenue and EBITDA Amid Strategic ...

Progyny Inc (PGNY) reported record revenue, gross profit, and adjusted EBITDA for Q2 2026, with revenue increasing 5.3% year-over-year. The company provided full-year 2026 guidance, projecting revenue between $1.36 billion and $1.385 billion, and reaffirmed strong selling season momentum and client retention. Despite a …

Cigna Wins Dismissal Of Pa. In-Network Pharmacy Suit

A Pennsylvania federal judge dismissed a lawsuit against Cigna, Evernorth, and Express Scripts. The suit was brought by pharmacy customers who claimed injury because their community pharmacy was designated as out-of-network. The article, authored by Kellie Mejdrich, was published on August 6, 2026, at …

Progyny Q2 2026 earnings: Margin expansion lifts profit faster than revenue

Progyny (Nasdaq: PGNY) reported Q2 2026 revenue of $350.5 million, a 5.3% year-over-year increase, and diluted EPS of $0.34, significantly up from $0.19 in Q2 2025. The company's profit growth outpaced revenue growth due to gross-margin expansion and lower stock-based compensation, despite a decline …

Alignment Healthcare, Inc. (ALHC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Alignment Healthcare, Inc. (ALHC) following allegations of accounting irregularities that artificially inflated the company's financial results. A former executive filed a whistleblower complaint, leading to a significant drop in Alignment's stock price on July …

Kaplan Fox Encourages Investors of Alignment Healthcare, Inc. (NASDAQ: ALHC) to Contact the Firm to Learn About Their Legal Rights

Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. (NASDAQ: ALHC) after news emerged of a whistleblower complaint. The complaint alleges accounting irregularities that artificially inflated the company's financial results and executive compensation. Following this news, Alignment Healthcare's stock …

Lowey Dannenberg, P.C. is Investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for Potential ...

Lowey Dannenberg P.C. is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for potential federal securities law violations. This follows a whistleblower lawsuit alleging the company manipulated its finances by misclassifying operating expenses as capital expenditures to inflate its adjusted EBITDA. The lawsuit claims this artificial …

ANTITRUST—E.D. Pa.: Humana’s generic-drug price-fixing claims will proceed to bellwether trial

The article reports that Humana's antitrust claims alleging generic drug price-fixing will proceed to a bellwether trial in the Eastern District of Pennsylvania. This indicates a significant development in the ongoing litigation, allowing a representative case to be tried to gauge potential outcomes for …

Earnings call transcript: Progyny beats Q2 2026 estimates, shares sink after hours

Progyny reported strong Q2 2026 results, beating adjusted EPS and revenue estimates with $0.55 per share and $350.51 million, respectively. Despite record financial performance, shares fell 15.59% in after-hours trading due to management's comments on a more pronounced summer slowdown impacting Q3 guidance. The …

Centene (CNC) Stock May Be Cheap Following Raised 2026 Outlook

Earnings Flash (DFTX) Definium Therapeutics Posts Q2 EPS -$1.44, vs. FactSet Est of -$0.54

Definium Therapeutics (DFTX) reported a Q2 EPS of -$1.44, significantly missing the FactSet estimate of -$0.54. The company's Q2 loss widened, as announced on August 6, 2026, alongside their earnings call. Definium Therapeutics focuses on developing treatments for psychiatric and neurological disorders, with its …

Progyny (PGNY) Q2 Earnings and Revenues Beat Estimates

Progyny’s (NASDAQ:PGNY) Q2 CY2026: Beats On Revenue But Stock Drops 10.2%

Centene Corp. stock underperforms Thursday when compared to competitors

Centene Corp. (CNC) stock dropped 4.16% on Thursday, closing at $64.20, thereby underperforming its competitors. This decline occurred during a generally poor trading session where the S&P 500 Index fell 0.18% and the Dow Jones Industrial Average dropped 0.85%. The stock's fall ended a …

Earnings Flash (GEN) Gen Digital Inc. Reports Q1 Revenue $1.34B, vs. FactSet Est of $1.31B

Gen Digital Inc. (GEN) reported its Q1 revenue at $1.34 billion, surpassing the FactSet estimate of $1.31 billion. The company also expects its Q2 revenue to be in the range of $1.32 billion to $1.35 billion, with adjusted EPS projected between $0.71 and $0.73. …

Progyny, Inc. Announces Second Quarter 2026 Results

Progyny, Inc. announced strong financial results for the second quarter of 2026, with revenue increasing by 5.3% to $350.5 million and net income rising to $28.1 million. The company reported record quarterly revenue, gross profit, and Adjusted EBITDA, driven by high member engagement and …

(PGNY) Progyny, Inc. Expects Q3 Revenue Range $335.0M - $345.0M

Progyny, Inc. (PGNY) announced its revenue expectations for the third quarter, projecting a range of $335.0 million to $345.0 million. This announcement follows their second-quarter earnings report, where the company posted revenues of $350.5 million, exceeding FactSet's estimate of $348.6 million, and an adjusted …

Autodesk's Fiscal Q2 Sales Track Steady as Partners Adapt to New Model, Oppenheimer Says

Oppenheimer reports that Autodesk's fiscal Q2 sales are holding steady as its partners adjust to a new operational model. This suggests a stable performance for the software company despite recent price target adjustments by other firms and ongoing market shifts, including increased investment in …

Oscar Health Announces Record Financial Results for First Half 2026 and Raises Full Year 2026 Outlook

Oscar Health, Inc. (NYSE: OSCR) reported record financial results for the first half of 2026, including significant increases in total revenue and net income, and has raised its full-year 2026 financial guidance. The company's CEO, Mark Bertolini, attributed this success to superior operating performance, …

Pacer Advisors Inc. Buys 144,073 Shares of Progyny, Inc. $PGNY

Pacer Advisors Inc. significantly increased its stake in Progyny, Inc. (NASDAQ:PGNY) by 49.4% in the first quarter, acquiring 144,073 additional shares and bringing their total holdings to 435,558 shares valued at approximately $7.4 million. This comes as Progyny exceeded first-quarter earnings expectations with an …

How Oscar Health’s 2026 Profit Turnaround And Guidance Upgrade At Oscar Health (OSCR) Has Changed Its Investment Story

ALHC INVESTOR ALERT: Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors Urged to Contact Hagens Berman; Investigation Opened Following Disappointing Second-Quarter Results and Whistleblower Allegations

Hagens Berman Sobol Shapiro LLP has initiated an investigation into Alignment Healthcare, Inc. (NASDAQ: ALHC) following disappointing second-quarter 2026 financial guidance and serious whistleblower allegations. The investigation focuses on potential securities law violations, specifically concerning whether the company misled investors about profitability and expense …

UBS Adjusts Price Target on Sight Sciences to $8 From $7, Maintains Buy Rating

UBS has increased its price target for Sight Sciences (SGHT) to $8 from $7, while reiterating a Buy rating on the stock. This adjustment follows Sight Sciences' Q2 2026 earnings call and news of FDA 510(k) clearance for its OMNI Ultra Surgical System. The …

Oscar Health Stock Sinks Amid This Second-Half Risk

FMR LLC reports 3.6% Molina Healthcare (MOH) stake in updated ownership filing

FMR LLC has filed an amended Schedule 13G, disclosing a beneficial ownership of 1,871,290.18 shares, or 3.6%, of Molina Healthcare Inc. common stock as of June 30, 2026. The filing indicates that FMR LLC holds sole dispositive power over all these shares and sole …